Advances in Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing

Download All
Gain insights into the latest advances in NTRK fusion testing and recent advances in tumor-agnostic TRK inhibition through expert-guided discussion.
George D. Demetri, MD
Alexander Drilon, MD
Pashtoon M. Kasi, MD, MS

Downloadable Slidesets

Download this slideset for expert perspectives on current best practices in testing for NTRK fusions in solid tumors.

George D. Demetri, MD Released: July 10, 2020

Download this slideset for expert perspectives on current best practices in the use of approved TRK inhibitors for patients with solid tumors.

Pashtoon M. Kasi, MD, MS Released: July 10, 2020

Download this slideset for expert perspectives on emerging next-generation TRK inhibitors and their potential use in managing resistance to first-generation agents, as well key adverse events with TRK inhibitors and management strategies.

Alexander Drilon, MD Released: July 10, 2020
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bayer HealthCare Pharmaceuticals Inc.
Genentech

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings